Healthcare provider profile · identity verified

Stephen Dana Knowlton, M.D.

Family Practice · REIDSVILLE, NC · NPI 1003969874

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Alprazolam	Alprazolam	354	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	252	65
Atorvastatin Calcium	Atorvastatin Calcium	246	80
Gabapentin	Gabapentin	181	43
Albuterol Sulfate Hfa	Albuterol Sulfate	171	52
Levothyroxine Sodium	Levothyroxine Sodium	168	36
Lorazepam	Lorazepam	168	35
Pantoprazole Sodium	Pantoprazole Sodium	156	44
Potassium Chloride	Potassium Chloride	141	41
Zolpidem Tartrate	Zolpidem Tartrate	121	25
Amlodipine Besylate	Amlodipine Besylate	110	34
Hydrochlorothiazide	Hydrochlorothiazide	107	39
Furosemide	Furosemide	104	33
Losartan Potassium	Losartan Potassium	97	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	96	22
Ondansetron Hcl	Ondansetron Hcl	95	27
Eliquis	Apixaban	94	15
Lisinopril	Lisinopril	94	31
Omeprazole	Omeprazole	84	29
Fluticasone Propionate	Fluticasone Propionate	82	32
Metoprolol Succinate	Metoprolol Succinate	81	22
Fluoxetine Hcl	Fluoxetine Hcl	73	18
Prednisone	Prednisone	73	28
Diazepam	Diazepam	72	11
Clonazepam	Clonazepam	71	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	17
Metformin Hcl	Metformin Hcl	66	17
Oxycodone Hcl	Oxycodone Hcl	63	13
Duloxetine Hcl	Duloxetine Hcl	56	14
Escitalopram Oxalate	Escitalopram Oxalate	53	suppressed
Ozempic	Semaglutide	52	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	46	13
Pregabalin	Pregabalin	46	suppressed
Trazodone Hcl	Trazodone Hcl	45	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	22
Pravastatin Sodium	Pravastatin Sodium	43	16
Tamsulosin Hcl	Tamsulosin Hcl	42	12
Atenolol	Atenolol	39	13
Ezetimibe	Ezetimibe	37	suppressed
Glimepiride	Glimepiride	37	14
Diclofenac Sodium	Diclofenac Sodium	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	34	suppressed
Jardiance	Empagliflozin	34	suppressed
Tramadol Hcl	Tramadol Hcl	33	suppressed
Clonidine Hcl	Clonidine Hcl	32	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Metformin Hcl Er	Metformin Hcl	32	14
Lovastatin	Lovastatin	30	suppressed
Symbicort	Budesonide/Formoterol Fumarate	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Mounjaro	Tirzepatide	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	11
Clopidogrel	Clopidogrel Bisulfate	27	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Meloxicam	Meloxicam	26	suppressed
Promethazine Hcl	Promethazine Hcl	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Sertraline Hcl	Sertraline Hcl	25	suppressed
Simvastatin	Simvastatin	24	suppressed
Carisoprodol	Carisoprodol	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Amoxicillin	Amoxicillin	21	suppressed
Naproxen	Naproxen	21	suppressed
Cefuroxime	Cefuroxime Axetil	20	14
Famotidine	Famotidine	20	suppressed
Methotrexate	Methotrexate Sodium	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Levofloxacin	Levofloxacin	19	14
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Imipramine Hcl	Imipramine Hcl	18	suppressed
Linzess	Linaclotide	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Azithromycin	Azithromycin	17	15
Chlorthalidone	Chlorthalidone	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Glipizide	Glipizide	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	suppressed
Finasteride	Finasteride	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Cilostazol	Cilostazol	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	13	suppressed
Estradiol	Estradiol	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Risperidone	Risperidone	13	suppressed
Torsemide	Torsemide	13	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Nystatin	Nystatin	11	suppressed
Temazepam	Temazepam	11	suppressed
Topiramate	Topiramate	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error